SCHEMBL423892

SCHEMBL423892

C=CCOC(=O)C1CCC(C(=O)OCC=C)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
CYP3A4 P08684 1/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 2/20 0.39
MAPT P10636 5/20 0.37
TSHR P16473 4/20 0.37
CACNA1B Q00975 1/20 0.37
APBA1 Q02410 1/20 0.37
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
PKM P14618 1/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL719931 1.00
SCHEMBL11769670 0.92 KMT2A (0.41) KMT2ACYP3A4ALDH1A1GAAMAPT
SCHEMBL1219520 0.92 KMT2A (0.41) KMT2ACYP3A4ALDH1A1GAAMAPT
SCHEMBL7133197 0.91 ALDH1A1 (0.41) KMT2ACYP3A4ALDH1A1GAAMAPT
SCHEMBL6350238 0.91 ALDH1A1 (0.44) KMT2ACYP3A4ALDH1A1GAAMAPT
SCHEMBL29108660 0.90 KMT2A (0.44) KMT2AALDH1A1GAAMAPTTSHR
SCHEMBL15443543 0.90 KMT2A (0.40) KMT2ACYP3A4ALDH1A1GAAMAPT
SCHEMBL4713300 0.90 KMT2A (0.40) KMT2ACYP3A4ALDH1A1GAAMAPT
SCHEMBL15442993 0.90 KMT2A (0.40) KMT2ACYP3A4ALDH1A1GAAMAPT
SCHEMBL4713299 0.90 KMT2A (0.40) KMT2ACYP3A4ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125574-A1 COATINGS P2I LTD (GB) 2026-05-07 US claimed
EP-3699353-B1 COATINGS P2I LTD (GB) 2026-04-01 EP claimed
EP-4049841-B1 HYBRID RESIN COMPOSITION CUBICURE GMBH (AT) 2026-03-18 EP claimed
US-20260055222-A1 PHOTOCURABLE COMPOSITION AND ITS APPLICATION IN PHOTOCURING FIELDS Huizhou Huahong New Materials Co., Ltd. (CN) 2026-02-26 US claimed
US-12528966-B2 Coatings P2I LTD (GB) 2026-01-20 US claimed
US-12410283-B2 Photopolymerizable thermoplastics and methods of making and using same THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2025-09-09 US claimed
US-12390987-B2 Hybrid resin composition for the 3D-printing of objects CUBICURE GMBH (AT) 2025-08-19 US claimed
US-20250133661-A1 MASKING METHOD AND MASKED PRODUCT P2I LTD (GB) 2025-04-24 US claimed
EP-3307835-B2 COATINGS P2I LTD (GB) 2025-04-02 EP claimed
EP-4473805-A1 MASKING METHOD AND MASKED PRODUCT P2i Ltd (GB) 2024-12-11 EP claimed
EP-3307835-B1 COATINGS P2I LTD (GB) 2019-05-08 EP claimed
WO-2016198857-A9 COATINGS P2I LTD (GB) 2018-07-05 WO claimed
US-20180171171-A1 COATINGS P2I LTD. (GB) 2018-06-21 US claimed
EP-3307835-A1 COATINGS P2i Ltd (GB) 2018-04-18 EP claimed
US-20170349708-A1 ACTIVE ENERGY RAY-CURABLE COMPOSITION AND USE THEREOF SHOWA DENKO K.K. (JP) 2017-12-07 US claimed
EP-3239210-A1 ACTIVE ENERGY RAY-CURABLE COMPOSITION, AND USE THEREOF Showa Denko K.K. (JP) 2017-11-01 EP claimed
US-9534104-B2 Plasticizer blends and use thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2017-01-03 US claimed
WO-2016198857-A1 COATINGS P2I LTD (GB) 2016-12-15 WO claimed
WO-2015112285-A1 PLASTICIZER BLENDS AND USE THEREOF EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-07-30 WO claimed
US-20140315021-A1 Plasticizer Blends and Use Thereof EXXONMOBIL CHEMICAL PATENTS INC. 2014-10-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260055222-A1 PHOTOCURABLE COMPOSITION AND ITS APPLICATION IN PHOTOCURING FIELDS HTR3D, EPB41, INTS9 KMT2A 2100/4885CYP3A4 128/4885ALDH1A1 330/4885
US-20260125574-A1 COATINGS SLC9A1, F9, F11 KMT2A 3050/4885CYP3A4 1650/4885ALDH1A1 817/4885
US-12528966-B2 Coatings C9, SDC1, CD59 KMT2A 2549/4885CYP3A4 1088/4885ALDH1A1 1446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.